Page 1 | Search Results | Hematology, ASH Education Program

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.

https://doi.org/10.1182/hematology.2019000032

Published: 2019

Journal Articles

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

David C. Fajgenbaum

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 318–325.

https://doi.org/10.1182/asheducation-2018.1.318

Published: 2018

Journal Articles

Biology-driven developments in the therapy of acute graft-versus-host disease

Robert Zeiser

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 236–241.

https://doi.org/10.1182/asheducation-2018.1.236

Published: 2018

Journal Articles

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

W. Robert Liu, Margaret A. Shipp

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 310–316.

https://doi.org/10.1182/asheducation-2017.1.310

Published: 2017

Journal Articles

Ph-like acute lymphoblastic leukemia

Thai Hoa Tran, Mignon L. Loh

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 561–566.

https://doi.org/10.1182/asheducation-2016.1.561

Published: 2016

Journal Articles

Targeting signaling pathways in acute lymphoblastic leukemia: new insights

Christine J. Harrison

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 118–125.

https://doi.org/10.1182/asheducation-2013.1.118

Published: 2013

Journal Articles

Novel therapy for Hodgkin lymphoma

Connie Lee Batlevi, Anas Younes

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 394–399.

https://doi.org/10.1182/asheducation-2013.1.394

Published: 2013

Journal Articles

New insights in the biology of Hodgkin lymphoma

Ralf Küppers

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 328–334.

https://doi.org/10.1182/asheducation.V2012.1.328.3798326

Published: 2012

Journal Articles

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

Adrian Wiestner

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 88–96.

https://doi.org/10.1182/asheducation.V2012.1.88.3801172

Published: 2012

Journal Articles

Signal Transduction Inhibitor Therapy for Lymphoma

Thomas E. Witzig, Mamta Gupta

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 265–270.

https://doi.org/10.1182/asheducation-2010.1.265

Published: 2010

Journal Articles

Genetic Pathways in the Pathogenesis of Therapy-Related Myelodysplasia and Acute Myeloid Leukemia

Jens Pedersen-Bjergaard, Morten T. Andersen, Mette K. Andersen

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 392–397.

https://doi.org/10.1182/asheducation-2007.1.392

Published: 2007

NARROW

Indolent lymphomas: pushing the pace with novel agents

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

Biology-driven developments in the therapy of acute graft-versus-host disease

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

Ph-like acute lymphoblastic leukemia

Targeting signaling pathways in acute lymphoblastic leukemia: new insights

Novel therapy for Hodgkin lymphoma

New insights in the biology of Hodgkin lymphoma

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

Signal Transduction Inhibitor Therapy for Lymphoma

Genetic Pathways in the Pathogenesis of Therapy-Related Myelodysplasia and Acute Myeloid Leukemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only